Form SC 13G - Statement of Beneficial Ownership by Certain Investors
08 November 2024 - 6:55AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
GALECTO, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.00001 PER SHARE
(Title of Class of Securities)
36322Q107
(CUSIP Number)
DECEMBER 31, 2020
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
* |
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 36322Q107 |
|
13G |
|
Page 2 of 9 Pages |
|
|
|
|
|
|
|
1. |
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION
NO. OF ABOVE PERSONS (ENTITIES ONLY) Sunstone Life Science Ventures Fund III
K/S |
2. |
|
CHECK THE APPROPRIATE BOX IF A
MEMBER OF A GROUP (a) ☐ (b) ☒
|
3. |
|
SEC USE ONLY
|
4. |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Denmark |
|
|
|
|
|
|
|
NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5. |
|
SOLE VOTING POWER
1,475,802* |
|
6. |
|
SHARED VOTING POWER
0 |
|
7. |
|
SOLE DISPOSITIVE POWER
1,475,802* |
|
8. |
|
SHARED DISPOSITIVE POWER
0 |
|
|
|
|
|
|
|
9. |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,475,802* |
10. |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
11. |
|
PERCENT OF CLASS REPRESENTED BY
AMOUNT IN ROW 9 5.8%* |
12. |
|
TYPE OF REPORTING PERSON
PN |
* |
Represents shares of Common Stock, par value $0.00001 per share (Common Stock) held by Sunstone
Life Science Ventures Fund III K/S (Sunstone Fund III). Sunstone LSV General Partner III ApS (Sunstone LSV GP III) is the general partner of Sunstone Fund III and may be deemed to have voting and dispositive power with
respect to the shares held by Sunstone Fund III. Sunstone Life Science Ventures A/S is the owner of Sunstone LSV GP III and may be deemed to have voting and dispositive power with respect to the shares held by Sunstone Fund III. The percent of class
was calculated based upon 25,261,832 shares of Common Stock of the Issuer outstanding as of March 25, 2021, as reported in the Issuers annual report on Form 10-K filed with the Securities and
Exchange Commission on March 29, 2021. |
|
|
|
|
|
CUSIP No. 36322Q107 |
|
13G |
|
Page 3 of 9 Pages |
|
|
|
|
|
|
|
1. |
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION
NO. OF ABOVE PERSONS (ENTITIES ONLY) Sunstone LSV General Partner III
ApS |
2. |
|
CHECK THE APPROPRIATE BOX IF A
MEMBER OF A GROUP (a) ☐ (b) ☒
|
3. |
|
SEC USE ONLY
|
4. |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Denmark |
|
|
|
|
|
|
|
NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5. |
|
SOLE VOTING POWER
1,475,802* |
|
6. |
|
SHARED VOTING POWER
0 |
|
7. |
|
SOLE DISPOSITIVE POWER
1,475,802* |
|
8. |
|
SHARED DISPOSITIVE POWER
0 |
|
|
|
|
|
|
|
9. |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,475,802* |
10. |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
11. |
|
PERCENT OF CLASS REPRESENTED BY
AMOUNT IN ROW 9 5.8%* |
12. |
|
TYPE OF REPORTING PERSON
OO |
* |
Represents shares of Common Stock held by Sunstone Fund III. Sunstone LSV GP III is the general partner of
Sunstone Fund III and may be deemed to have voting and dispositive power with respect to the shares held by Sunstone Fund III. Sunstone Life Science Ventures A/S is the owner of Sunstone LSV GP III and may be deemed to have voting and dispositive
power with respect to the shares held by Sunstone Fund III. The percent of class was calculated based upon 25,261,832 shares of Common Stock of the Issuer outstanding as of March 25, 2021, as reported in the Issuers annual report on Form 10-K filed with the Securities and Exchange Commission on March 29, 2021. |
|
|
|
|
|
CUSIP No. 36322Q107 |
|
13G |
|
Page 4 of 9 Pages |
|
|
|
|
|
|
|
1. |
|
NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION
NO. OF ABOVE PERSONS (ENTITIES ONLY) Sunstone Life Science Ventures
A/S |
2. |
|
CHECK THE APPROPRIATE BOX IF A
MEMBER OF A GROUP (a) ☐ (b) ☒
|
3. |
|
SEC USE ONLY
|
4. |
|
CITIZENSHIP OR PLACE OF
ORGANIZATION
Denmark |
|
|
|
|
|
|
|
NUMBER OF
SHARES BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH |
|
5. |
|
SOLE VOTING POWER
1,475,802* |
|
6. |
|
SHARED VOTING POWER
0 |
|
7. |
|
SOLE DISPOSITIVE POWER
1,475,802* |
|
8. |
|
SHARED DISPOSITIVE POWER
0 |
|
|
|
|
|
|
|
9. |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,475,802* |
10. |
|
CHECK BOX IF THE AGGREGATE
AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐ |
11. |
|
PERCENT OF CLASS REPRESENTED BY
AMOUNT IN ROW 9 5.8%* |
12. |
|
TYPE OF REPORTING PERSON
OO |
* |
Represents shares of Common Stock held by Sunstone Fund III. Sunstone LSV GP III is the general partner of
Sunstone Fund III and may be deemed to have voting and dispositive power with respect to the shares held by Sunstone Fund III. Sunstone Life Science Ventures A/S is the owner of Sunstone LSV GP III and may be deemed to have voting and dispositive
power with respect to the shares held by Sunstone Fund III. The percent of class was calculated based upon 25,261,832 shares of Common Stock of the Issuer outstanding as of March 25, 2021, as reported in the Issuers annual report on Form 10-K filed with the Securities and Exchange Commission on March 29, 2021. |
|
|
|
|
|
CUSIP No. 36322Q107 |
|
13G |
|
Page 5 of 9 Pages |
Item 1(a). |
Name of Issuer: |
Galecto, Inc. (the Issuer).
Item 1(b). |
Address of Issuers Principal Executive Offices: |
75 State Street, Suite 100, Boston, MA 02109.
Item 2. |
Name of Person Filing: |
(a) (c) |
Name of Persons Filing; Address; Citizenship |
This statement on Schedule 13(G) is being filed jointly by the following persons, each a Reporting Person:
|
i. |
Sunstone Life Science Ventures Fund III K/S, a Danish limited partnership; |
|
ii. |
Sunstone LSV General Partner III ApS, a Danish private limited company. Sunstone LSV General Partner III ApS is
the general partner of Sunstone Life Science Ventures Fund III K/S; and |
|
iii. |
Sunstone Life Science Ventures A/S, a Danish public limited liability company. Sunstone Life Science Ventures
A/S is the owner of Sunstone LSV General Partner III ApS. |
The principal business address of the Reporting Persons
is Store Strandstræde 18, DK-1255 Copenhagen, Denmark.
Item 2(d). |
Title of Class of Securities: |
Common Stock, par value $0.00001 per share.
36322Q107
The information set forth in rows 5 through 11 of the cover pages is incorporated herein by reference into this Item 4.
Calculations are based on 25,261,832 shares of Common Stock of the Issuer outstanding as of March 25, 2021, as reported in the
Issuers annual report on Form 10-K filed with the Securities and Exchange Commission on March 29, 2021.
Item 5. |
Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than 5 percent of the class of securities, check the following ☐.
|
|
|
|
|
CUSIP No. 36322Q107 |
|
13G |
|
Page 6 of 9 Pages |
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable.
Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the
Parent Holding Company. |
Not applicable.
Item 8. |
Identification and Classification of Members of the Group. |
Not applicable.
Item 9. |
Notice of Dissolution of Group. |
Not applicable.
Not Applicable.
|
|
|
|
|
CUSIP No. 36322Q107 |
|
13G |
|
Page 7 of 9 Pages |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: November 7, 2024
|
Sunstone Life Science Ventures Fund III K/S |
|
By: Sunstone LSV General Partner III ApS Its:
General Partner By: Sunstone Life Science Ventures A/S Its:
Owner /s/ Søren Lemonius
Name: Søren Lemonius Title: Managing Member
/s/ Merete Lundbye Møller
Name: Merete Lundbye Møller Title: Managing
Member |
|
Sunstone LSV General Partner III ApS |
|
By: Sunstone Life Science Ventures A/S Its:
Owner /s/ Søren Lemonius
Name: Søren Lemonius Title: Managing Member
/s/ Merete Lundbye Møller
Name: Merete Lundbye Møller Title: Managing
Member |
|
Sunstone Life Science Ventures A/S |
|
/s/ Søren Lemonius
Name: Søren Lemonius Title: Managing Member
/s/ Merete Lundbye Møller
Name: Merete Lundbye Møller Title: Managing
Member |
|
|
|
|
|
CUSIP No. 36322Q107 |
|
13G |
|
Exhibit 99.1
Page 8 of 9 Pages |
Joint Filing Agreement
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent
amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of
such amendments, and for the completeness and accuracy of the information concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except
to the extent that he, she or it knows or has reason to believe that such information is inaccurate.
Dated: November 7, 2024
|
Sunstone Life Science Ventures Fund III K/S |
|
By: Sunstone LSV General Partner III ApS Its:
General Partner By: Sunstone Life Science Ventures A/S Its:
Owner /s/ Søren Lemonius
Name: Søren Lemonius Title: Managing Member
/s/ Merete Lundbye Møller
Name: Merete Lundbye Møller Title: Managing
Member |
|
Sunstone LSV General Partner III ApS |
By: Sunstone Life Science Ventures A/S Its:
Owner /s/ Søren Lemonius
Name: Søren Lemonius Title: Managing Member |
|
/s/ Merete Lundbye Møller
Name: Merete Lundbye Møller Title: Managing
Member |
|
|
|
|
|
CUSIP No. 36322Q107 |
|
13G |
|
Page 9 of 9 Pages |
|
Sunstone Life Science Ventures A/S |
|
/s/ Søren Lemonius
Name: Søren Lemonius Title: Managing Member
/s/ Merete Lundbye Møller
Name: Merete Lundbye Møller Title: Managing
Member |
Galecto (NASDAQ:GLTO)
Historical Stock Chart
From Nov 2024 to Dec 2024
Galecto (NASDAQ:GLTO)
Historical Stock Chart
From Dec 2023 to Dec 2024